The Anticonvulsant Drug Development (ADD) Program is involved in identification and characterization of novel Drugs for Epilepsy and is the ETSP- contract site.

ID: 1149356968265433088

linkhttps://pharmacy.utah.edu/add/ calendar_today11-07-2019 16:37:10